HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Madhukar Rai Selected Research

Acquired Immunodeficiency Syndrome (AIDS)

11/2015Outcome of patients on second line antiretroviral therapy under programmatic condition in India.
1/2014Study the drug adherence and possible factor influencing drug adherence in HIV/AIDS patients in north eastern part of India.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Madhukar Rai Research Topics

Disease

27Visceral Leishmaniasis (Kala Azar)
11/2021 - 12/2002
7Leishmaniasis
01/2015 - 12/2002
5Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2016 - 07/2013
2Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2020 - 12/2017
2Insulin Resistance
03/2020 - 12/2017
2Neoplasms (Cancer)
01/2020 - 04/2013
2Acquired Immunodeficiency Syndrome (AIDS)
11/2015 - 01/2014
2Infections
01/2013 - 01/2013
1Duodenal Ulcer (Curling's Ulcer)
06/2020
1Gastritis
06/2020
1Cardiovascular Diseases (Cardiovascular Disease)
03/2020
1Genetic Predisposition to Disease (Genetic Predisposition)
03/2020
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2020
1Blast Crisis (Blast Phase)
01/2020
1Acute-Phase Reaction
01/2020
1Papillomavirus Infections
12/2018
1Hypothyroidism
12/2017
1Obesity
12/2017
1Autoimmune Diseases (Autoimmune Disease)
02/2016
1Brain Diseases (Brain Disorder)
10/2013
1Seizures (Absence Seizure)
10/2013
1Glomerulonephritis
07/2013
1Neuroendocrine Tumors (Neuroendocrine Tumor)
04/2013
1Carcinoid Tumor (Carcinoid)
04/2013
1Neuroendocrine Carcinoma
04/2013
1Communicable Diseases (Infectious Diseases)
01/2013
1Body Weight (Weight, Body)
02/2010
1Hepatocellular Carcinoma (Hepatoma)
08/2007
1Thalassemia
06/2005
1Cutaneous Leishmaniasis
12/2002

Drug/Important Bio-Agent (IBA)

5AutoantibodiesIBA
02/2016 - 07/2013
5AntigensIBA
12/2015 - 04/2012
5miltefosine (Impavido)IBA
01/2015 - 12/2002
5Amphotericin B (Amphotericin)FDA LinkGeneric
01/2014 - 02/2004
4Pharmaceutical PreparationsIBA
10/2012 - 12/2002
3Paromomycin (Paromomycin Sulfate)FDA LinkGeneric
11/2021 - 09/2009
3LipidsIBA
03/2020 - 02/2004
3RNA (Ribonucleic Acid)IBA
01/2016 - 05/2014
3Nuclear Antigens (Extractable Nuclear Antigens)IBA
12/2015 - 07/2013
3liposomal amphotericin BFDA Link
03/2015 - 12/2002
2CytokinesIBA
01/2020 - 10/2014
2MicroRNAs (MicroRNA)IBA
02/2016 - 05/2014
2Messenger RNA (mRNA)IBA
10/2014 - 07/2013
2deoxycholate drug combination amphotericin BIBA
08/2008 - 02/2004
2AntimonyIBA
03/2006 - 12/2002
1AntralIBA
06/2020
1Blood Glucose (Blood Sugar)IBA
03/2020
1Interleukin-6 (Interleukin 6)IBA
01/2020
1Interferon Type IIBA
01/2020
1InterferonsIBA
01/2019
1Interleukin-2 (IL2)IBA
01/2019
1Thyroxine (Levothyroxine)FDA LinkGeneric
12/2017
1ChemokinesIBA
10/2014
1Interleukin-12 (IL 12)IBA
10/2014
1GraphiteIBA
01/2014
1AminesIBA
01/2014
1Metronidazole (Metric)FDA LinkGeneric
10/2013
1N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA
10/2013
1Biological ProductsIBA
04/2013
1Proteins (Proteins, Gene)FDA Link
01/2013
1Biomarkers (Surrogate Marker)IBA
01/2013
1Kinetoplast DNA (kDNA)IBA
01/2013
1LigandsIBA
08/2012
118S Ribosomal RNAIBA
06/2012
1Carbon Nanotubes (Carbon Nanotube)IBA
01/2012
1Interleukin-10 (Interleukin 10)IBA
10/2011
1InsecticidesIBA
12/2010
1leishmaninIBA
04/2009
1PolyestersIBA
12/2007
1Polyethylene (Polythene)IBA
12/2007
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2007
1beta-Globins (beta Globin)IBA
06/2005
1S(8)IBA
06/2005
1Fluconazole (Zonal)FDA LinkGeneric
12/2002
18-aminoquinolineIBA
12/2002

Therapy/Procedure

6Therapeutics
03/2020 - 12/2002
2Highly Active Antiretroviral Therapy (HAART)
03/2020 - 01/2014
1Art Therapy
11/2015
1Length of Stay
10/2013
1Duration of Therapy
02/2011